ライフサイエンスコーパス: scleral

1 cidence of corneal (60% vs. 40%; P = 0.007), scleral (19% vs. 9%; P = 0.044), and orbital (13% vs. 3%

2 scence (5.3%), suture exposure (5.3%) (trans-scleral 9-0 polypropylene), and vitreous strand at infer

3 The difference between scleral and corneal IOP (IOPs - IOPk) correlated positiv

4 o evaluate reliability and agreement between scleral and corneal measurements of IOP.

5 Scleral and corneal pneumatonometry showed nearly 1:1 li

6 patients with histopathologically confirmed scleral and/or intraocular invasion of SCC at Wills Eye

7 tumors and with higher incidence of corneal, scleral, and orbital invasion.

8 ctival injection or by intraoperative direct scleral application using surgical sponges during trabec

9 livery (subconjunctival injection and direct scleral application) resulted in comparable surgical out

10 al studies of the excised sclera revealed no scleral architectural changes or abnormal deposits.

11 he sclera was thick, no abnormal microscopic scleral architecture could be identified.

12 ains to be shown whether and how the altered scleral biomechanics may affect the rate of glaucoma pro

13 (stromal choroidal thickness, SCT), or inner scleral border (total choroidal thickness, TCT) showed n

14 choroid, including the shape of the choroid-scleral border, location of the thickest point of choroi

15 flectivity with partial visualization of the scleral boundary), and type C (hyporeflective with compl

16 eflective with complete visualization of the scleral boundary).

17 Clinical features correlated with posterior scleral bowing included reduced distance to the optic di

18 Choroidal nevus can show focal posterior scleral bowing on EDI-OCT in 5% of cases.

19 Recognition of posterior scleral bowing with choroidal nevus is essential to avoi

20 All cases demonstrated posterior scleral bowing with mean scleral excavation of 398 micro

21 emonstrated the EDI-OCT feature of posterior scleral bowing.

22 re vitrectomy (88%), combined vitrectomy and scleral buckle (8%), and encirclement (3%).

23 included peripheral laser ablation (n = 3), scleral buckle (n = 2), pars plicata vitrectomy (n = 2),

24 who underwent vitrectomy with a supplemental scleral buckle (n = 488) had an increased failure rate c

25 tly lower failure rate versus treatment with scleral buckle (P = 7x10(-8)).

26 al buckle (SB) or vitrectomy with or without scleral buckle (PPV+/-SB) between 2013 and 2016.

27 with pars plana vitrectomy (PPV) or PPV with scleral buckle (PPV-SB).

28 a primary noncomplex RD repair with either a scleral buckle (SB) or vitrectomy with or without sclera

29 R, pars plana vitrectomy (PPV), and combined scleral buckle (SB) plus PPV (SB+PPV).

30 In addition, an encircling scleral buckle (SB) was used in 2 cases.

31 my (PPV), 413 (12.1%) were retinopexy with a scleral buckle (SB), and 297 (8.7%) were PPV with an SB

32 RD treated with pars plana vitrectomy (PPV), scleral buckle (SB), or PPV plus SB over an 11-year peri

33 tinal detachments (RRDs) can be treated with scleral buckle (SB), pars plana vitrectomy (PPV), or SB

34 gnificantly higher success rate with primary scleral buckle (SB; 63%; OR, 2.2; 95% CI, 1.1-4.5) and c

35 ory of left eye rhegmatogenous RD treated by scleral buckle 1 month after the last IAC and cataract s

36 plana vitrectomy [PPV], laser barricade, or scleral buckle [SB]) were collected.

37 failure rate was higher when treated with a scleral buckle alone versus vitrectomy (P = 0.0017).

38 grees underwent PPV combined with encircling scleral buckle and 360 degrees laser retinopexy of the p

39 the risks and benefits of vitrectomy versus scleral buckle and keep in mind that the single-surgery

40 on (49%), followed by laser barricade (23%), scleral buckle and pneumatic retinopexy (both 11%), and

41 lana vitrectomy (PPV; 15 patients), combined scleral buckle and PPV (4 patients), pneumatic retinopex

42 Scleral buckle and PPV/SB were superior to PPV for SSAS

43 Scleral buckle and vitrectomy combined with belt buckle

44 st savings of 62% and 60.8% when compared to scleral buckle and vitrectomy, respectively.

45 s and potential cost savings comparing PR to scleral buckle and vitrectomy.

46 pars plana vitrectomy (1/19, 5.3%), and post-scleral buckle exposure (1/19, 5.3%).

47 er in the vitrectomy group compared with the scleral buckle group (P = 3x10(-8)).

48 outside institution before referral, or if a scleral buckle had been placed.

49 ted phakic retinal detachments, repair using scleral buckle may be a good option.

50 third eye had a history of high myopia and a scleral buckle procedure for retinal detachment.

51 Scleral buckle surgery was performed, but 3 weeks later

52 ercentage of eyes that underwent vitrectomy, scleral buckle surgery, and pneumatic retinopexy were 71

53 detachment after retinoblastoma therapy and scleral buckle surgery.

54 c retinopexy was found to be comparable with scleral buckle when a retinal hole was present (P = 0.65

55 vice (intraocular lens, glaucoma implant, or scleral buckle).

56 ined pars plana vitrectomy (PPV), encircling scleral buckle, 360 degrees Laser endophotocoagulation,

57 ely treated with PPV coupled with encircling scleral buckle, 360 degrees laser retinopexy and silicon

58 , surgical techniques, including vitrectomy, scleral buckle, and pneumatic retinopexy, are the only m

59 y and silicone oil tamponade with or without scleral buckle, drainage retinotomy, or relaxing retinec

60 ore likely to have the repair performed with scleral buckle, laser barricade, and pneumatic retinopex

61 egular corneal astigmatism in keratoconus or scleral-buckle-induced regular astigmatisms can be equal

62 L implantation in two cases - a patient with scleral-buckle-induced regular corneal astigmatism and a

63 r of toric IOL implantation in patients with scleral-buckle-induced regular corneal astigmatism.

64 hment and grade C PVR after primary encircle scleral buckling (SB group - 12 eyes), or pars plana vit

65 To investigate the effect of scleral buckling (SB) on the morphology and density of h

66 Surgical repair was done either by scleral buckling (SB) or pars plana vitrectomy (PPV) acc

67 ents undergoing pars plana vitrectomy (PPV), scleral buckling (SB), and combined PPV/SB for primary R

68 index studies) of pneumatic retinopexy (PR), scleral buckling (SB), pars plana vitrectomy (PPV), and

69 Initial surgery using scleral buckling alone was performed in most (8 of 13, 6

70 Scleral buckling declined from 6502 procedures in 2000 t

71 t in eyes with history of retinoblastoma and scleral buckling developing tractional RD.

72 atism (>2.5 diopter) were caused by previous scleral buckling in one case and by keratoconus in the o

73 enous RD in BD can be effectively treated by scleral buckling in selected cases and PPV in more compl

74 Scleral buckling leads to short-term decreased endotheli

75 Novel surgical tools, including bioerodible scleral buckling materials and artificial vitreous subst

76 Previous scleral buckling or pars plana vitrectomy seem to have n

77 plana vitrectomy (PPV) alone versus combined scleral buckling plus PPV (SB+PPV).

78 Scleral buckling plus PPV resulted in greater SOAS outco

79 Scleral buckling plus PPV showed greater SOAS than PPV a

80 a vitrectomy (PPV), 50% underwent encircling scleral buckling plus PPV, 18.8% underwent repeat PPV, a

81 .8% underwent repeat PPV, and 6.2% underwent scleral buckling plus repeat PPV.

82 ) and silicone oil tamponade with or without scleral buckling procedure (SBP) for recurrent RD due to

83 The patient underwent a scleral buckling procedure with a small segmental buckle

84 Scleral buckling sharply declined, and preference for re

85 ype of a new indenter marker was used during scleral buckling surgery.

86 my with a distribution of 83% vitrectomy, 5% scleral buckling, and 12% pneumatic retinopexy in 2014.

87 were performed between pneumatic retinopexy, scleral buckling, and vitrectomy.

88 retinal detachment with surgical treatment (scleral buckling, vitrectomy, or pneumatic retinopexy).

89 ne peeling, tamponade choice, and concurrent scleral buckling, were constructed to assess association

90 f stage 4A ROP in the right eye and received scleral buckling.

91 e introduction of peripheral iridectomy with scleral cautery (thermal sclerostomy) in the 1950s and t

92 lped" in conjunctival, corneal, retinal, and scleral cells, similar to the behavior observed in macro

93 DT lumen appeared as scleral collagen second harmonic generation signal voids

94 We compare scleral coloration and its relative contrast with the ir

95 now that great apes show diverse patterns of scleral coloration.

96 meibomian gland heating and expression, and scleral contact lenses are some of the latest options av

97 and pain following retinal examination using scleral depression.

98 The newly developed scleral depressor marker facilitated simultaneous indent

99 onstrated posterior scleral bowing with mean scleral excavation of 398 microm (median, 377 microm; ra

100 We hypothesize that scleral expansion at the location of these perforating v

101 ring PPV are male sex, advancing age, RRD, a scleral explant, a dropped lens fragment, and the use of

102 asound in the diagnostic management of extra scleral extension in choroidal melanoma".

103 d massive choroidal invasion (4/38) or trans-scleral, extraocular, and postlaminar optic nerve invasi

104 prelaminar/laminar optic nerve invasion, or scleral/extrascleral infiltration.

105 At 15 weeks, thickness of scleral fibrosis was greater in GS (246 +/- 47 mum) and

106 eratoplasty (DMEK) in patients with existing scleral-fixated and iris-fixated intraocular lenses (sf-

107 antations is a valid alternative strategy to scleral-fixated or angle-supported IOL implantation.

108 chamber intraocular lens, 2 patients with a scleral-fixated posterior chamber intraocular lens (PCIO

109 e found between groups operated with Hoffman scleral fixation and Sharioth technique.

110 This modified, simple way of scleral fixation of an IOL decreases the duration of sur

111 Patients who underwent combined PPV and scleral fixation of an IOL with Gore-Tex suture were ide

112 All eyes underwent scleral fixation of either an Akreos A060 or enVista MX6

113 The scleral fixation suture was 9-0 polypropylene in 16 eyes

114 Hoffman haptic scleral fixation was performed in 31 eyes, Sharioth tech

115 l acuity (VA), IOP, number of sutures in the scleral flap, laser suture lysis, surgeon, and lateralit

116 ation of a GMS+ by means of a full-thickness scleral flap.

117 ar scleral tunnel underneath the superficial scleral flap.

118 acuity, intraocular pressure, and trends in scleral grading.

119 he majority of their dendritic arbors to the scleral half or "Off" sublamina of the inner plexiform l

120 erior chamber IOL implantation using Hoffman scleral haptic fixation and sutureless Sharioth techniqu

121 of the sclera and the presence or absence of scleral hyporeflective areas representing intrascleral e

122 revealed a palpable mass in the epigastrium; scleral icterus was absent.

123 During vitrectomy and under scleral indentation at 5-o'clock position, a cilium was

124 eyes should be approached with caution when scleral indentation is attempted due to the possibility

125 Examination with scleral indentation of the RE revealed 2 peripheral smal

126 idal and optic nerve invasion (n = 17, 12%), scleral infiltration (n = 20, 14%), and extrascleral inv

127 Control of scleral inflammation and pain was achieved in all but 2

128 atment is usually effective in reducing both scleral inflammation and symptoms and possibly reduces t

129 2-step reduction or reduction to grade 0 in scleral inflammation on a 0 to +4 scale according to a s

130 The scleral inflammation subsided but later the keratitis re

131 sirolimus leads to a short-term reduction in scleral inflammation, though relapses requiring reinject

132 e presence of AK with concurrent ipsilateral scleral inflammation.

133 une, non-necrotizing anterior scleritis with scleral inflammatory grade of >/=1+ in at least 1 quadra

134 s, non-necrotizing anterior scleritis with a scleral inflammatory grade of +1 to +3 in at least 1 eye

135 eny the human brain detects social cues from scleral information even in the absence of conscious awa

136 r the ability to respond to social cues from scleral information without conscious awareness exists e

137 muscle margins oversewn to the poles of the scleral insertion, avoiding the anterior ciliary arterie

138 ), and hyporeflective gradation at the nevus-scleral interface (P = .33).

139 vessels (P = 1), visualization of the nevus-scleral interface (P = .6), and hyporeflective gradation

140 Visualization of the complete nevus-scleral interface was significantly (P = .02) more appar

141 Scleral intraocular lens (IOL) fixation is an accepted t

142 all cases with residual tumor demonstrating scleral invasion (n = 15) and/or anterior chamber invasi

143 In eyes with residual tumor showing scleral invasion or intraocular involvement, enucleation

144 ting postlaminar optic nerve, choroidal, and scleral invasion showed sensitivities of 59% (95% CI, 37

145 oidal and 13 with scleral invasion], 12 with scleral invasion without postlaminar optic nerve invasio

146 ary body, optic nerve, choroidal, and (extra)scleral invasion.

147 th concomitant massive choroidal and 13 with scleral invasion], 12 with scleral invasion without post

148 tive alternative to enucleation for residual scleral-invasive conjunctival SCC following resection.

149 Limbal, corneal, and/or scleral involvement were present in 70.4%, 42.6%, and 27

150 the resection margin of the optic nerve and scleral involvement, but only the former was independent

151 To now, no long-term data on scleral IOL fixation in MFS exist.

152 the following equation: corneal IOP = 1.04 x scleral IOP - 10.37.

153 d for determination of whether the choroidal-scleral junction (CSJ) could be visualized and for measu

154 phy (EDI-OCT) require a well-defined choroid-scleral junction (CSJ), which may appear in some eyes as

155 he retinal pigment epithelium to the choroid-scleral junction at 500-mum intervals up to 2500 mum nas

156 (0.750-0.869), even in eyes where choroidal-scleral junction visibility was <75%.

157 I-OCT images were obtained and the choroidal-scleral junction was analyzed through semiautomated segm

158 Two graders marked the choroidal-scleral junction with segmentation software using differ

159 t to follow-up, 4 eyes abandoned wearing the scleral lens because of an inability to handle the lense

160 investigate the success and failure rates of scleral lens correction in severe keratoconus.

161 The scleral lens fitting process can be completed efficientl

162 vey mailed to all patients who completed the scleral lens fitting process to evaluate the long-term s

163 s, 115 (188 eyes) successfully completed the scleral lens fitting process, and therapeutic goals (imp

164 Scleral lens fitting was completed in an average of 3 vi

165 Scleral lens fitting was proposed for the 75 eyes includ

166 of 27 eyes of 17 MFS patients that underwent scleral lens fixation at our clinic between 1999 and 201

167 Scleral lens fixation in MFS patients achieves satisfyin

168 Here, a fluorescent scleral lens sensor is developed to quantitatively measu

169 2 patients (346 eyes) who were evaluated for scleral lens therapy for the management of ocular surfac

170 process to evaluate the long-term success of scleral lens therapy in the management of ocular surface

171 The most common indications for scleral lens therapy were undifferentiated ocular surfac

172 ee patients experienced complications during scleral lens wear that resolved without loss of visual a

173 Visual acuity improved with scleral lens wear, from 0.32 +/- 0.37 logarithm of the m

174 ery were successfully treated with long-term scleral lens wear.

175 nge, 0-8) other forms of intervention before scleral lens wear.

176 oss of visual acuity, enabling resumption of scleral lens wear.

177 ultiplexed in the concavities of an engraved scleral lens.

178 0.19 logMAR (Snellen equivalent, 20/26) with scleral lenses (P<0.001).

179 Commercially available scleral lenses can be successfully used in the managemen

180 n addition to protecting the ocular surface, scleral lenses improve visual acuity in patients whose s

181 Scleral lenses were prescribed in 51 of 75 eyes.

182 se but has not been reported to present with scleral manifestation.

183 Differences between serial scleral measurements reflect differences between serial

184 cytosis (P = .02), and 1.9 times higher with scleral melanocytosis (P < .001).

185 r control, 1 showed revascularization of the scleral melt, and 1 required orbital exenteration.

186 Associated features included dermal (n = 6), scleral (n = 9), iris (n = 3), and palate (n = 1) melano

187 Scleral necrosis after plaque radiotherapy of uveal mela

188 of factors that predicted clinically evident scleral necrosis included ciliary body (P = 0.0001) and

189 Treatment of scleral necrosis included observation in 81% of patients

190 Scleral necrosis occurred in <1% of patients (3/1140) wh

191 Scleral necrosis remained stable in 48% of patients (35/

192 ime interval between plaque radiotherapy and scleral necrosis was 32 months (median, 23 months; range

193 The mean basal dimension of scleral necrosis was 4 mm (median, 3 mm; range, 1-15 mm)

194 Another patient developed scleral necrosis, secondary infectious scleritis, and in

195 noma, 73 (1%) developed radiotherapy-induced scleral necrosis.

196 In addition, 1 was implanted for scleral necrosis.

197 who presented with an asymptomatic superior scleral nodule for 4 months, which showed similar appear

198 Surgical debridement of the scleral nodule was performed.

199 be included in the differential diagnosis of scleral nodules even in the absence of systemic symptoms

200 mer who presented with 2 nontender right eye scleral nodules for 3 months, had a negative systemic wo

201 time to the best of our knowledge 2 cases of scleral nodules with typical histopathological morpholog

202 (39%), RD with retinal incarceration in the scleral or corneal wound or both (13%), media opacity wi

203 eyes of 30 patients with unilateral anterior scleral or episcleral inflammation.

204 heme of these anomalies is the presence of a scleral (or lamina cribrosa) defect permitting anomalous

205 The conically arranged scleral ossicles define a small pupil, indicative of diu

206 ation before January 2016 had surgery with a scleral patch graft covering the distal end of the tube,

207 ed therapeutic keratoplasty, combined with a scleral patch graft in 1 eye, 1 eye was eviscerated afte

208 uded observation in 81% of patients (59/73), scleral patch graft in 14% of patients (10/73), and enuc

209 AADI placed without a scleral patch graft is as safe and effective as AADI pla

210 Scleral patches from rabbit eyes were cross-linked using

211 agic clot as self-blockage site of posterior scleral penetrating trauma, allowed for surgical stabili

212 in 48% of patients (35/73), or progressed to scleral perforation in 4% of patients (3/73) over a mean

213 e evidence of spontaneously healed posterior scleral perforation in a severe ballistic trauma without

214 Intraoperative scleral perforation or retinal redetachment related to t

215 ery, and 11% of cases develop intraoperative scleral perforation or retinal redetachment.

216 l membrane, vitreoretinal traction, optic or scleral pit, or advanced glaucomatous optic nerve change

217 l pachymetry and serial corneal and temporal scleral pneumatonometry (baseline, immediately after, an

218 nts included corneal pneumatonometry (IOPk), scleral pneumatonometry (IOPs), axial length (AL), spher

219 Scleral pneumatonometry averaged 9.0 mmHg higher than co

220 Scleral pneumatonometry correlates positively with corne

221 When adjusted for age, scleral pneumatonometry may be an adequate alternative i

222 One-time baseline corneal and scleral pneumatonometry readings were obtained in the no

223 Scleral pneumatonometry should be considered as an alter

224 owed nearly 1:1 linear correlation, although scleral pneumatonometry was biased toward higher values

225 The difference between corneal and scleral pneumotonometry was correlated between the two e

226 s used, and the haptics were fixed under the scleral pockets inside a linear scleral tunnel underneat

227 ally opposed paralimbal, curved self-sealing scleral pockets were made 3 mm away from the limbus alon

228 Strikingly, the superior scleral region stood out as showing the strongest and mo

229 every 1% decrease in CPT code 67255 payment, scleral reinforcement with graft service volume increase

230 For scleral reinforcement with graft, the payment-volume ela

231 vascular architecture changes resulting from scleral remodeling after long-term tumor compression.

232 The scleral remodeling due to mass effect of retrobulbar tum

233 stologically normal sclera but responsive to scleral resection.

234 tions up to 24 h to elucidate differences in scleral resistance to enzymatic degradation.

235 sclera is a promising approach to strengthen scleral rigidity and thus to inhibit eye growth in progr

236 nsertion area under the Bruch's membrane and scleral rim.

237 is fabricated to excite as well as read the scleral sensor.

238 gle opening distance 500 mum anterior to the scleral spur (AOD500) were compared among the quadrants

239 IA), angle opening distance 500 mum from the scleral spur (AOD500), and iridotrabecular contact lengt

240 ngle opening distance (AOD) 500 mum from the scleral spur (median DeltaAOD500 = 103 mum; interquartil

241 ot visible and open if the angle was open to scleral spur and beyond.

242 AOD), trabecular iris space area (TISA), and scleral spur angle (SSA).

243 and 750 mum anterior from scleral spur), and scleral spur angle.

244 easured at both 500 mum and 750 mum from the scleral spur landmark.

245 hwork at 500 mum and 750 mum anterior to the scleral spur to the anterior iris surface (AOD500 and AO

246 ecular meshwork height was measured from the scleral spur to the Schwalbe line.

247 TISA, measured 500 and 750 mum anterior from scleral spur), and scleral spur angle.

248 (AOD, measured 500 and 750 mum anterior from scleral spur), the trabecular-iris-space area (TISA, mea

249 ult [LV], iris thickness at 750 mum from the scleral spur, and iris cross-sectional area) explain >80

250 r-iris space area (TISA500) 500 mum from the scleral spur, were made using the FD-OCT RTVue(R).

251 tissues, predominantly in the ciliary muscle/scleral spur, which together correspond to the uveoscler

252 gle recess area at 750 mum (ARA750) from the scleral spur.

253 d iris thickness (IT750) at 750 mum from the scleral spur.

254 d any part of the angle wall anterior to the scleral spur.

255 th were measured at 500 and 750 mum from the scleral spur: angle opening distance (AOD), trabecular i

256 ers measured at different distances from the scleral spur: angle opening distance at 250 mum (AOD250)

257 gle recess area at 750 mum (ARA750) from the scleral spur; and trabecular-iris angle (TIA).

258 mum (TISA500) and 750 mum (TISA750) from the scleral spur; angle recess area at 750 mum (ARA750) from

259 mum (TISA500) and 750 mum (TISA750) from the scleral spur; angle recess area at 750 mum (ARA750) from

260 mm (CMT2), and 3 mm (CMT3) posterior to the scleral spur; maximum (CMTMAX) thickness was also assess

261 mum (AOD500), and 750 mum (AOD750) from the scleral spur; trabecular-iris space area at 500 mum (TIS

262 mum (AOD500), and 750 mum (AOD750) from the scleral spur; trabecular-iris space area at 500 mum (TIS

263 nto the ciliary sulcus with or without trans-scleral suture fixation.

264 d for patients with a dislocated or subluxed scleral-sutured enVista MX60 IOL.

265 A total of 25 scleral-sutured enVista MX60 IOLs displacements secondar

266 Study Population: Patients with scleral-sutured enVista MX60 IOLs that experienced eithe

267 A scleral-sutured implant and an implantation in the capsu

268 r eyes undergoing pars plana vitrectomy with scleral-sutured IOL implantation, assumption of in-the-b

269 es include anterior chamber lenses, iris- or scleral-sutured lenses, and iris-claw lenses.

270 Scleral-sutured MX60 intraocular lenses can experience i

271 laucoma was highest in the 8-0 polypropylene scleral-sutured PCIOL group.

272 rior chamber IOL (PCIOL), 10-0 polypropylene scleral-sutured PCIOL, 8-0 polypropylene scleral-sutured

273 ene scleral-sutured PCIOL, 8-0 polypropylene scleral-sutured PCIOL, CV-8 polytetrafluoroethylene, and

274 ene iris-sutured PCIOL and 8-0 polypropylene scleral-sutured PCIOL.

275 ll, it was twice as common in both iris- and scleral-sutured PCIOLs (except CV-8 polytetrafluoroethyl

276 re randomly assigned to IOL repositioning by scleral suturing (n = 54) or IOL exchange with a retropu

277 assigned one group for IOL repositioning by scleral suturing (n = 54) or one group for IOL exchange

278 ts (104 eyes) either to IOL repositioning by scleral suturing (n = 54) or to IOL exchange with retrop

279 Ultrasound biomicroscopy (UBM) revealed scleral thickening with peripheral choroidal elevation l

280 of the staphyloma and secondary to excessive scleral thickening.

281 UBM can be helpful to evaluate scleral thickness and anterior choroid in equivocal case

282 The mean transconjunctival scleral thickness was 747 mum (SD +/- 68.97) with a rang

283 Underlying the nevus, the scleral thickness was not measurable; however, at the ne

284 Axial length and scleral thickness were measured after sacrifice in the C

285 Choroidal thickness, scleral thickness, and bulge height were positively corr

286 Retinal, choroidal, and scleral thicknesses and bulge height were measured on SD

287 ck of the eye-for a wide range of eye sizes, scleral thicknesses and intraocular pressures, and targe

288 Scleral thinning surgery may be considered a valid optio

289 reduced the enzymatic degradation of rabbit scleral tissue by MMP1.

290 g methods increased the resistance of rabbit scleral tissue to MMP1-degradation.

291 SPG-178 and the ocular tissue (in this case scleral) to clear the surgical field of view.

292 tion of fine needle aspiration biopsy (FNAB) scleral tracts to determine the incidence of iatrogenic

293 may indicate an increased facilitated trans-scleral transport of nanoparticle carboplatin, with a su

294 ed under the scleral pockets inside a linear scleral tunnel underneath the superficial scleral flap.

295 d underwent surgery using a needle-generated scleral tunnel without the patch graft.

296 a, and the relationships between perforating scleral vessels and retinal-choroidal structures.

297 Perforating scleral vessels are often present beneath the site at wh

298 measures were the prevalence of perforating scleral vessels at the site of the lacquer crack, the po

299 photoreceptor loss and myopia with increased scleral wall elasticity.

300 Scleral windows or vortex decompressions are usually per